Disrupting the brain’s orbitofrontal cortex with a noninvasive stimulation technique impairs a person’s ability to make inference-based decisions and may help treat psychiatric disorders, according to a recent Northwestern Medicine study.
Northwestern Medicine scientists have discovered that mutations in the largest genetic contributor to ALS leads to the dysfunction and eventual degeneration of certain specialized subtypes in the brain. The findings may lead to development of novel therapeutic interventions for the disease.
The development of oligodendrocytes are heavily influenced by an RNA epigenetic regulation mechanism, according to a new study.
Northwestern Medicine scientists were able to significantly reduce brain swelling and damage after a traumatic brain injury by injecting nanoparticles into the bloodstream.
A previously unknown migration of glioblastoma may explain why current treatments stall out over time, according to a new study.
Northwestern Medicine scientists have recently discovered that two common genetic risk factors for Parkinson’s disease can be regulated with LRRK2 kinase inhibition or GCase enzyme activation, revealing potential for the development of new therapeutics.
People who carry genetic mutations associated with an increased risk for Parkinson’s disease may exhibit minor symptoms long before the disease progresses to affect daily life, according to a study of over 300 patients.
Scientists have discovered a set of neural “conversations” underlying individual neurons’ activity during learned movements, findings with implications for the development of neuroprostheses.
A Northwestern Medicine study found that episodic memory may be improved through the use of noninvasive transcranial magnetic stimulation of the posterior medial network in the hippocampus.